EU’s Tightened Regulatory Checks Delay Cipla’s HFA Inhaler Launches
This article was originally published in PharmAsia News
You may also be interested in...
As Cipla Battles Roche, Chairman Calls For India National Patent Pool To Lower Drug Prices
MUMBAI - Cipla Chairman Yusuf Hamied - known for his stance against patenting highly priced drugs - has appealed for the creation of a national patent pool, rather than an international patent pool, to combat neglected diseases like HIV, tuberculosis, malaria and diseases prevalent in the developing world
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).